ProActive Remedies, LLC Announces Launch of New Allergy Medication
Posted on: Thursday, 27 March 2008, 12:00 CDT
WINDSOR, Colo., March 27 /PRNewswire/ -- A new patent-pending allergy medication and treatment method is available over the counter as an alternative to allergy shots. ProActive Remedies, LLC announced today that it has begun selling ALLERTHERAPY for the treatment of allergies. The oral immunotherapy spray helps allergy sufferers by building immunity to a wide variety of targeted allergens through the administration of low homeopathic concentrations of such allergens. Over time, this treatment may save money for allergy sufferers through decreased doctor visits, absences, medications, and complications by reducing allergic reactions. ProActive Remedies, LLC sells directly to allergy sufferers through its online store at http://www.allertherapy.com/.
To date, ProActive Remedies, LLC has brought to market the ALLERTHERAPY Pollen Mix medication, and anticipates releasing food, environment, and combination mixes this spring. ProActive Remedies, LLC's ALLERTHERAPY line offers an assortment of features including multi-regional, multi-seasonal formulas, a wide variety of targeted allergens, reduced dependence upon allergy medications -- including ALLERTHERAPY itself -- over time, and a 30 Day Unconditional Guarantee. Treatment can reduce the severity of allergic reactions by fifty percent or more. This translates into substantial future savings. Additional benefits to allergy sufferers are the improvements in lifestyle that come with increased allergen tolerance. Improved indoor and outdoor comfort, improved tolerance of pets, and the ability to widen the variety of foods in the food allergy sufferer's diet are among the advantageous results of the ALLERTHERAPY Treatment Method.
According to American Academy of Allergy Asthma & Immunology (AAAAI) estimates, more than twenty percent of Americans are affected by allergic diseases. These allergic diseases are the sixth leading cause of chronic diseases in Americans. In 1996, allergic rhinitis was estimated to have an overall cost of $6 billion in the U.S. The AAAAI also notes that up to 90 percent of those with seasonal allergic rhinitis and up to 80 percent of those with perennial allergic rhinitis are able to successfully treat their condition with immunotherapy. Not all patients qualify for allergy shots, or are able to commit to the rigorous schedule of appointments. The ALLERTHERAPY line of liquid immunotherapy spray is simple to administer and available over the counter as an alternative treatment option. Those with serious allergies or other medical conditions should use ALLERTHERAPY under doctor supervision only. For more information about ALLERTHERAPY, please visit the website at http://www.allertherapy.com/. Orders may be placed online or by calling 1 (877) GO-ALLER or 1 (877) 462-5537.
For additional information, contact: Contact Person: Connie Williams Company: ProActive Remedies, LLC Phone: (800) 874-0989 ext. 300 Fax: (703) 637-9893 Email: information@proactiveremedies.com Online: http://www.allertherapy.com/ Phone Orders: (877) GO-ALLER / (877) 462-5537
ProActive Remedies, LLC is dedicated to developing products that empower consumers. The company conducts extensive research to define consumer needs and to develop and market cutting-edge products. The release of ALLERTHERAPY is the result of this process.
This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com/.
ProActive Remedies, LLC
CONTACT: Connie Williams of ProActive Remedies, LLC, +1-800-874-0989ext. 300, Fax: +1-703-637-9893, information@proactiveremedies.com
Web site: http://www.allertherapy.com/
Source: PRNewswire
Related Articles
- Pramlintide and Leptin Combination Treatment Demonstrates 12.7 Percent Weight Loss in 24-Week Clinical Obesity Study
- Veramyst Effective in Allergic Rhinitis According to Study
- CyberKnife(R) System Extracranial Treatments Grow 75 Percent in Fiscal Year 2007 Demonstrating Radiosurgery Market Shift
- Robin Williams' Decision to Enter Rehab for Alcoholism is a Proactive, Positive Step in Treating the Illness, CEO of New Seasons Recovery Says
- AUDIO From Medialink: Choosing the Right Allergy Relief
- Dynavax Announces Rapid, Expanded Enrollment in Ragweed Allergy Pediatric Trial
- Myocardial Infarction After Aspirin Treatment, and Kounis Syndrome
- La. Expert: Allergies a Problem Year-Round Head of Asthma, Allergy Group Urges Continuous Monitoring, Treatment to Fight Disease
- Positive Single-Season Phase 1 Data on Dynavax's AIC Ragweed Allergy Therapy Presented at AAAAI Meeting
User Comments (0)

RSS Feeds